Ann Lin, a former intern in the lab of CSHL Fellow Jason Sheltzer, has been named one of the top entrepreneurs of the Forbes 30 Under 30 2020 list. She is one of the youngest winners in the Science category.
As part of the Sheltzer lab, she helped discover that a successful cancer drug didn’t work as previously thought. They found that the drug does not actually hit the intended target, but succeeds in fighting cancer as a coincidental side effect. This research is leading to the development and implementation of new procedures that can better confirm on-target activity of proposed cancer treatments.
Lin started working at CSHL when she was an undergraduate student at Stony Brook University. What drew Lin to working in Sheltzer’s lab was not the subject matter, but Sheltzer himself, who had been named a Forbes 30 Under 30 in 2015.
“I remember being so impressed with him when I saw he was on the Forbes 30 Under 30 and I told myself, I’m going to join this person’s lab,” Lin said. “He’s young and he’s motivated and he seemed like he would be a great mentor. And he really is an amazing mentor!”
Lin is currently a Ph.D. candidate at Stanford University.